Boon N A, Aronson J K, Hallis K F, Grahame-Smith D G
Clin Sci (Lond). 1986 Jun;70(6):611-6. doi: 10.1042/cs0700611.
In order to study cation transport in vivo we have measured the changes in plasma and intra-erythrocytic rubidium concentrations after the oral administration of rubidium chloride. In this paper we describe our findings in 22 patients with untreated essential hypertension, compared with the findings in 22 carefully matched control subjects. Our findings in patients receiving short-term digoxin therapy and in patients with chronic renal failure are also included for comparison. Whereas the findings in patients receiving digoxin and in patients with chronic renal failure are compatible with a widespread reduction in sodium, potassium-ATPase activity in vivo, the findings in patients with untreated essential hypertension are not. Further analysis of the data and a similar study of the disposition of 42K after the intravenous administration of 42KCl suggest that in vivo net cation transport is enhanced in the erythrocytes of patients with untreated essential hypertension.
为了研究体内阳离子转运,我们测定了口服氯化铷后血浆和红细胞内铷浓度的变化。在本文中,我们描述了22例未经治疗的原发性高血压患者的研究结果,并与22例精心匹配的对照受试者的结果进行了比较。我们还纳入了接受短期地高辛治疗的患者和慢性肾衰竭患者的研究结果以作比较。接受地高辛治疗的患者和慢性肾衰竭患者的研究结果与体内钠钾ATP酶活性普遍降低相符,而未经治疗的原发性高血压患者的研究结果并非如此。对数据的进一步分析以及静脉注射42KCl后对42K处置的类似研究表明,未经治疗的原发性高血压患者红细胞内的体内净阳离子转运增强。